Avidity Biosciences, Inc. announced on January 4, 2022, Joseph Baroldi informed the company of his intention to resign as Chief Operating Officer of the Company to pursue a new opportunity. His last day at the Company will be January 21, 2022. The Company has entered into a post-employment consulting agreement with Mr. Baroldi for a term of six months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.45 USD | -0.07% | -6.95% | +203.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+203.31% | 2.63B | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- Avidity Biosciences, Inc. Announces Resignation of Joseph Baroldi as Chief Operating Officer, Effective January 22, 2022